Elliot Sigal, Director at Spark Therapeutics, Inc. (ONCE), sold 29 shares at $72.43 ($2K) on 2017-11-28, disclosed to the SEC on 2018-04-16.
Open-market sale of $2k ONCE by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| BMY | SELL | 2013-05-31 | $6.8M | — | Filing → |
| BMY | SELL | 2013-05-01 | $19.3M | — | Filing → |
| BMY | SELL | 2013-02-11 | $8.3M | — | Filing → |